Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
International Journal of Antimicrobial Agents|March 27, 2012
Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infectionsLeonard Amaral, Miguel Viveiros
Antibiotics (Basel, Switzerland)|January 19, 2017
Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of ActionLeonard Amaral, Miguel Viveiros
Future Microbiology|March 28, 2008
The TB laboratory of the future: macrophage-based selection of XDR-TB therapeuticsMarta Martins, Miguel Viveiros, Leonard Amaral
International Journal of Antimicrobial Agents|September 19, 2003
Mycobacterial efflux pumps and chemotherapeutic implicationsMiguel Viveiros, Clara Leandro, Leonard Amaral
In Vivo (Athens, Greece)|January 14, 2005
Antimicrobial activity of phenothiazinesLeonard Amaral, Miguel Viveiros, Joseph Molnar
In Vivo (Athens, Greece)|April 10, 2008
Inhibitors of Ca2+ and K+ transport enhance intracellular killing of M. tuberculosis by non-killing macrophagesMarta Martins, Miguel Viveiros, Leonard Amaral
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 4, 2018
Advances in the molecular diagnosis of tuberculosis: From probes to genomesDiana Machado, Isabel Couto, Miguel Viveiros
One Health (Amsterdam, Netherlands)|March 6, 2023
Antimicrobial resistance, society and environment: A glocal syndemicPaulo Ferrinho, Miguel Viveiros, Inês Fronteira
The Journal of Antimicrobial Chemotherapy|January 16, 2007
Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumpsLeonard Amaral, Marta Martins, Miguel Viveiros
Expert Review of Anti-Infective Therapy|May 22, 2020
Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugsLiliana Rodrigues, Pedro Cravo, Miguel Viveiros
Pageof 20